Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 174.75 USD 1.76%
Market Cap: 308.8B USD
Have any thoughts about
Abbvie Inc?
Write Note

P/OCF
Price to OCF

18.4
Current
11
Median
22.3
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
18.4
=
Market Cap
303.5B USD
/
Operating Cash Flow
16.5B USD
All Countries
Close
Market Cap P/OCF
US
Abbvie Inc
NYSE:ABBV
303.5B USD 18.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 094.9
US
Amgen Inc
NASDAQ:AMGN
155.8B USD 21.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.1B USD -137.8
US
Gilead Sciences Inc
NASDAQ:GILD
111.8B USD 11.2
US
Epizyme Inc
F:EPE
94.1B EUR -472.5
AU
CSL Ltd
ASX:CSL
132.3B AUD 31.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82B USD 19.3
US
Seagen Inc
F:SGT
39.3B EUR -76.3
NL
argenx SE
XBRU:ARGX
33.8B EUR -136.3
KY
Beigene Ltd
SSE:688235
233.5B CNY -39.6
 
US
Abbvie Inc
NYSE:ABBV
Average P/OCF: 20.3
18.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -238 094.9
US
Amgen Inc
NASDAQ:AMGN
21.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -137.8
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.5
AU
CSL Ltd
ASX:CSL
31.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.3
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.3
KY
Beigene Ltd
SSE:688235
Negative Multiple: -39.6

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More